GlassScriptPhysician profile
Mary Scott
NPI 1225588163
$2,685.11
in general payments reported to CMS, 2019-2025
15 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $754 · 2023: $1,025 · 2024: $610 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,825.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $824.58 | 2021-2024 | Abilify Mycite, Abilify Asimtufii, Abilify Maintena |
| Alkermes, INC. | $459.53 | 2021-2024 | Aristada, Lybalvi, Aristada Initio |
| Abbvie INC. | $365.06 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $240.72 | 2023-2024 | Austedo Xr |
| Janssen Pharmaceuticals, INC | $204.84 | 2021-2024 | Invega, Invega Sustenna, Invega Trinza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $191.31 | 2022-2025 | Caplyta |
| Amgen INC. | $91.08 | 2025 | Krystexxa |
| Axsome Therapeutics, INC. | $68.24 | 2022-2023 | Auvelity |
| Vanda Pharmaceuticals INC. | $62.08 | 2023-2024 | Fanapt, Hetlioz |
| Neurocrine Biosciences, INC. | $47.09 | 2023 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $40.69 | 2022 | |
| Indivior INC. | $28.95 | 2024 | Perseris |
| Dexcom, INC. | $23.55 | 2023 | Dexcom G6 Transmitter |
| Lundbeck LLC | $21.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.